Skip to main content
BMC Public Health logoLink to BMC Public Health
letter
. 2025 Apr 1;25:1230. doi: 10.1186/s12889-025-22525-6

Cutting through the fog: recognising brain fog as a significant public health concern

Darren Haywood 1,2,3,4,5,, Susan L Rossell 2,5, Nicolas H Hart 1,6,7,8,9
PMCID: PMC11959835  PMID: 40170152

Abstract

Brain fog is a highly common condition that can have significant impacts on quality of life and functioning. Most people will experience a condition, illness, or infection that might result in the development of brain fog. We provide a call to action to minimise the impacts of brain fog.

Keywords: Brain fog, Cognitive impairment, Call to action, Public health, Neurocognition, Cancer, Kidney disease, HIV, AIDS, COVID

Introduction

“Sorry, i’m feeling a little foggy today…”

The feeling of ‘brain fog’ is not uncommon [1], with more than a quarter of adults in the general population (28.2%) reporting experiencing it [1]. Brain fog can be reflected in many ways. Some days people might experience a slowing down of thoughts, trouble concentrating, a sense of confusion, or difficulties following conversations [1, 2]. Sometimes when people feel ’foggy’ they suggest potential causes, like consuming alcohol the night prior, or a lack of sleep [3]. While brain fog of this nature may last a few hours or a couple of days, for people experiencing brain fog as the result of other causes it can be a significantly debilitating condition that negatively impacts their lives and can last decades [4]. Long-term brain fog can also present episodically, with some experiencing periods of normal cognitive functioning disrupted by periods of significant brain fog that may last hours or days [1, 2]. Worryingly, the causes of long-term brain fog are not uncommon, thus it is probable that during our lives we will experience a condition, illness, or infection that might result in the development of longer-lasting brain fog [1, 3, 5].

In this Comment, we discuss what is known and not known about brain fog and demonstrate it as a significant global public health concern, while providing a call to action, including specific research directions, that are required to enhance our understanding, prevention, management, and treatment of brain fog globally.

What we know about brain fog

Brain fog is characterised by a slowing of thought and processing, difficulties remembering, slowing of responses, and communication difficulties, and is experienced across the population [1]. Particular subpopulations, such as people with long COVID-19, cancer, kidney dysfunction, HIV, hepatitis, fibromyalgia, pregnancy, or psychological challenges, often experience especially severe and long-lasting brain fog that might not remit [1, 3, 6, 7]. Brain fog has been acknowledged as a serious problem across these conditions for over two decades with exploratory research attempting to establish its causative mechanisms. While we are still improving our knowledge of brain fog’s aetiology, research within these vulnerable subpopulations points toward changes in factors like neuronal activity, inflammation, hormones, and nutritional deficiencies caused by their condition [8].

Brain fog can have a significant impact on people’s lives, including occupational functioning, relationships, psychological well-being, and performance of daily activities [1, 2]. This can result in not returning to work after an illness, missed days of work, poor productivity, and the inability to effectively care for children and support partners [2]. For example, people experiencing long-term brain fog may not feel confident returning to work due to their slower cognitive processing [2, 4] or have parental challenges [2, 4]. Lastly, brain fog often impacts self-perception, self-identify, and self-worth, leading to anxiety and depression [2, 4, 5].

Interventions seeking to improve cognitive dysfunction (‘brain fog’) continue to be studied, assessed, and developed [2]. There has been some success across these vulnerable subpopulations in reducing brain fog through non-pharmacological interventions such as physical activity or exercise, diet, cognitive rehabilitation (i.e., ‘brain training’), and psychological treatment [810], as well as pharmacological interventions [8]. However, treatments and supportive care strategies are far from consistently effective and are rarely implemented in clinical practice [9].

What we don’t know about brain fog

While we know brain fog is common and could be caused by a range of different factors, four important questions remain:

What is brain fog really?

Brain fog is commonly described across a variety of populations but what brain fog actually is remains unclear [3]. The experience of brain fog is often empirically captured via self-reported measures of perceived cognitive functioning, or sometimes supplemented by the use of objective measures of neuropsychological tests [1, 3]. These measures have historically assessed cognitive functioning generally (of which dysfunction is often characterised by brain fog), however there has been the recent development of a purpose-built self-report measure for brain fog specifically; called the Brain Fog Scale [11]. Problematically for clinicians and researchers, self-reported measures of perceived cognitive functioning do not strongly relate to its objective measures [12], apparent across populations. For example, some cancer survivors demonstrate cognitive impairments on self-report measures, but not objective measures, and others demonstrate the opposite [5, 8]. Therefore, whether brain fog is an objective cognitive dysfunction or something entirely different is not clear. Future co-design research with people who experience brain fog (from different conditions) and experts is required to develop a consistent definition.

Is brain fog the same ‘thing’ across all potential causes?

The experience of brain fog may have several different causes depending on the individual [1]. However, the reported experience of brain fog is remarkably similar across subpopulations (e.g., 2). It is unknown if brain fog, regardless of the cause, may be one consistent thing. This is important as it may suggest that there is potential for global, as well as specific, prevention, treatment, and supportive care approaches across subpopulations.

What can we do to prevent getting brain fog?

There is limited understanding about how we can prevent brain fog. There has been some progress in people with cancer and other subpopulations undergoing planned treatment for their condition [8]. Prehabilitation strategies using medication, more targeted treatments such as cognitive training, and lifestyle change show promise in minimising the anticipated occurrence and severity of brain fog [8]. However, for the broader population without planned treatments for a condition, empirically based approaches to prevent brain fog are limited.

If we do experience brain fog, what can we do about it?

While there has been some success in treating brain fog in specific subpopulations, strategies for minimising brain fog for the broader population are limited. Even the success of interventions for some sub-populations is variable and the lasting impact of the interventions on real-world functioning is questionable [13].

Brain fog as a significant global public health concern

For some, brain fog might last for a short period (e.g., a day or week), but for others, it can last decades [8]. While most available brain fog research is within subpopulations, brain fog is a broad and growing concern. In recent years, we have understood that COVID-19 infection can lead to experiencing brain fog [6], as one of the most commonly reported effects of acute and long-COVID [1, 6], and may last multiple years. With a significant proportion of the global population acquiring the COVID-19 infection, and approximately 62% experiencing long-COVID [6], brain fog is a global public health concern.

Beyond COVID, improvements to the treatment of conditions associated with increased risk of brain fog mean that more people with brain fog are living longer and require support. For example, the 5-year survival rate of cancer has significantly improved. In Australia, the 5-year survival rate for all cancer was 53% in the mid-1990s, and then 71% twenty years on [14]. Given that cancer and cancer treatments can cause brain fog in a significant number of cancer survivors, millions more people will experience lasting brain fog. This trend is similar for other conditions associated with brain fog, such as kidney disease [15].

We must urgently improve our understanding of brain fog and its management

Brain fog can have severe impacts on people’s lives and those close to them across various domains [2, 4], however changes to cognitive functioning (including for brain fog) are also related to the development of psychological disorders [5]. Therefore, given the rising number of people experiencing lasting brain fog globally, the condition has significant implications for (a) the global economy through missed days of work and healthcare costs, (b) the healthcare burden through increased comorbidities, treatment and supportive care needs, and (b) the quality of life of the person with brain fog and those close to them.

Call to action

Below (in Fig. 1) we provide a call for urgent action to minimise brain fog and its consequences with the goal of ultimately minimising brain fog’s impact on global health, sociality, and economy.

Fig. 1.

Fig. 1

Call to action to address brain fog

Acknowledgements

Not applicable.

Author contributions

Conceptualisation: DH. Writing-original draft preparation: D.H. Writing-review and editing: D.H, S.L.R, and N.H.H. Visualisation: D.H and N.H.H.

Funding

No funding was received for the completion of this work. N.H.H receives salary support from the National Health and Medical Research Council (NHMRC) as an Investigator Fellow (APP2018070). D.H is a MASCC Cognition Fellow.

Data availability

No datasets were generated or analysed during the current study.

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

D.H and N.H.H are BMC Series Editors; N.H.H is a Senior Editorial Board Member of BMC Cancer, and D.H is an Editorial Board Member of BMC Psychology. The authors declare no other competing interests.

Supervision

N.H.H and S.R

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Alim-Marvasti A, Ciocca M, Kuleindiren N, Lin A, Selim H, Mahmud M. Subjective brain fog: a four-dimensional characterization in 25,796 participants. Front Hum Neurosci. 2024;18:1409250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Haywood D, Dauer E, Baughman FD, Lawrence BJ, Rossell SL, Hart NH, et al. Is my brain ever going to work fully again?? Challenges and needs of cancer survivors with persistent cancer-Related cognitive impairment. Cancers. 2023;15(22):5331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ross AJ, Medow MS, Rowe PC, Stewart JM. What is brain fog? An evaluation of the symptom in postural tachycardia syndrome. Clin Auton Res. 2013;23:305–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Haywood D, Wallace IN, Lawrence B, Baughman FD, Dauer E, O’Connor M. Oncology healthcare professionals’ perceptions and experiences of ’chemobrain’ in cancer survivors and persons undergoing cancer treatment. Gen Hosp Psychiatry. 2023;84:271–2. [DOI] [PubMed]
  • 5.Haywood D, Henry M, Dauer E, Lederman O, Farley M, Henneghan AM, et al. Cancer-related cognitive impairment as a key contributor to psychopathology in cancer survivors: implications for prevention, treatment and supportive care. Support Care Cancer. 2024;32(7):1–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, et al. Long COVID syndrome‐associated brain fog. J Med Virol. 2022;94(3):979–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Haywood D, Chan A, Chan RJ, Baughman FD, Dauer E, Dhillon HM, et al. The MASCC COG-IMPACT: an unmet needs assessment for cancer-related cognitive impairment impact developed by the multinational association of supportive care in cancer. Support Care Cancer. 2025;33(2):120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Mayo SJ, Lustberg M, Dhillon M, Nakamura H, Allen ZM, Von Ah DH. Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC neurological complications study group. Support Care Cancer. 2021;29:2821–40. [DOI] [PubMed] [Google Scholar]
  • 9.Altman RAE, Reser M, Tan EJ, Rossell SL. Cognitive remediation for schizophrenia: clinician perspectives on implementation barriers and facilitators. Rehabil Psychol. 2024;69(2):171–83. [DOI] [PubMed]
  • 10.Haywood D, Henneghan A, Chan A, Chan RJ, Dhillon HM, Lustberg MB, et al. The effect of non-pharmacological interventions on cognitive function in cancer: an overview of systematic reviews. Support Care Cancer. 2025;33:151. [DOI] [PMC free article] [PubMed]
  • 11.Debowska A, Boduszek D, Ochman M, Hrapkowicz T, Gaweda M, Pondel A, et al. Brain fog scale (BFS): scale development and validation. Pers Indiv Differ. 2024;216:112427. [Google Scholar]
  • 12.Dang J, King KM, Inzlicht M. Why are self-report and behavioral measures weakly correlated? Trends Cogn Sci. 2020;24(4):267–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hallion LS, Hsu KJ, Schleider JL. Cognitive training for mental health problems. Nat Mental Health. 2024;2(1):17–24. [Google Scholar]
  • 14.Australian Institute of Health and Welfare. Cancer Data in Australia 2024 [Available from: https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/contents/overview
  • 15.Brodski J, Rossell SL, Castle DJ, Tan EJ. A systematic review of cognitive impairments associated with kidney failure in adults before natural age-related changes. J Int Neuropsychol Soc. 2019;25(1):101–14. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

No datasets were generated or analysed during the current study.


Articles from BMC Public Health are provided here courtesy of BMC

RESOURCES